USA SCIENCE DNA EDITING
epa06122150 An undated composite handout photo made available by the Oregon Health & Science University (OHSU) on 03 August 2017 shows a sequence of the development of embryos after co-injection of a gene-correcting enzyme and sperm from a donor with a genetic mutation known to cause hypertrophic cardiomyopathy. A team of researchers at Oregon Health & Science University, in Portland, Oregon, USA, has demonstrated an effective method to correct a disease-causing gene mutation in human embryos and stopping it from passing to future generations. The technique, using the gene-editing tool CRISPR (clustered regularly interspaced short palindromic repeats), targets a mutation in nuclear DNA (deoxyribonucleic acid) that causes hypertrophic cardiomyopathy (HCM), a common inherited disease that can cause sudden cardiac death and heart failure in both men and women of any age. The research was published in the journal Nature on 02 August 2017. EPA/OREGON HEALTH & SCIENCE UNIVERSITY HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALES
Samo prijavljeni korisnici mogu preuzeti fotografiju u punoj kvaliteti.